Androgen receptor blocking drug is-
**Question:** Androgen receptor blocking drug is-
A. Flutamide
B. Bicalutamide
C. Enzalutamide
D. Abiraterone
**Core Concept:**
The question pertains to androgen receptor signaling and its blockade, which plays a crucial role in the development and progression of prostate cancer. Androgens, such as testosterone, bind to androgen receptors (ARs) in prostate cancer cells, promoting their growth and survival. Blocking these receptors can help suppress tumor progression.
**Why the Correct Answer is Right:**
The correct answer, D. Abiraterone, is a specific inhibitor of the CYP17 enzyme, which is essential for testosterone synthesis. By inhibiting this enzyme, abiraterone effectively lowers circulating levels of androgens, leading to reduced AR activation and subsequent suppression of prostate cancer cell growth.
**Why Each Wrong Option is Incorrect:**
A. Flutamide (B) and Bicalutamide (C) are nonsteroidal antiandrogens, meaning they directly bind to the androgen receptor, blocking its interaction with endogenous androgens. However, they are not as potent as the steroidal AR inhibitors, such as abiraterone.
D. Enzalutamide (A) is another steroidal AR inhibitor, but it is structurally different from abiraterone. While both drugs target the androgen receptor, abiraterone's mechanism of action differs from enzalutamide, making it an incorrect choice in this context.
**Clinical Pearl:**
Prostate cancer relies on androgen signaling for growth and progression. Understanding the various compounds targeting androgen receptors is crucial for treating and managing patients with prostate cancer. Abiraterone, being a potent steroidal inhibitor of androgen synthesis, is particularly effective for advanced prostate cancer patients with castration-resistant disease.